Welcome to the OMA Blog

The Obesity Medicine Association (OMA) is pleased to announce a new multi-phase Quality Improvement (QI) initiative designed to strengthen obesity care delivery across diverse outpatient clinical settings in the United States. OMA is also partnering with Q Synthesis LLC, a healthcare quality improvement company, to develop and implement key components of the initiative. At the heart of the program is the Implementation into Practice Collaborative (IPC) , a virtual learning collaborative that will run from February through May 2026.

The Obesity Medicine Association (OMA) welcomes today’s announcement by the White House Administration regarding expanded access to obesity medications and a commitment to make effective treatment for the chronic disease of obesity more affordable and widely available.

The Trump Administration has announced a proposed plan for a five-year pilot program that will allow patients with Medicare or Medicaid access to anti-obesity medications.

The AMA held its Annual Meeting in Chicago from June 6–11, 2025. I was honored to continue in this role and was joined by our alternate delegate, Dr. Jennifer Paisley. I’d like to share several highlights from this year’s meeting.

The Obesity Medicine Association (OMA) announced its 2025 Award Winners at the recent Obesity Medicine 2025 Conference in National Harbor, MD, this April. ABOM Candidate of the Year Award Presented to the OMA member who scored the highest on the American Board of Obesity Medicine Certification Examination Recipient: Johanna Elizabeth Tran, MD, DABOM The Steelman-Seim Educator Award for Excellence in Academics Recipient: Silvana Pannain, MD Dr.

Dr. Leslie Golden’s journey into obesity medicine was shaped by both personal experience and a deep-rooted passion for improving patient care.

January 27, 2025 – The Obesity Medicine Association (OMA) acknowledges the Lancet Commission’s effort to refine obesity diagnosis with the introduction of “preclinical” and “clinical” obesity classifications. However, we express significant concerns about the potential unintended consequences of this framework, which risks redefining obesity from a disease to merely a risk factor, undermining decades of progress in recognizing obesity as a chronic, progressive and relapsing multifactorial disease.

Explore the milestones, innovations, and advocacy efforts that have shaped the field, from early beginnings to modern breakthroughs. Join us in honoring the past and advancing the future of obesity medicine.

Effective October 1, 2024, new ICD-10-CM codes for both adult and childhood obesity will become available, representing a significant shift in the way obesity is diagnosed and managed in clinical settings.